Single clinical case after analytically confirmed melanotan II exposure
How the study was set up
A case report describes a man hospitalized after using an internet-purchased product; mass spectrometry confirmed Melanotan II in the tested substance.
What the researchers measured
Symptoms, heart rate, kidney function, and creatine kinase, a marker of muscle injury, were tracked during hospitalization.
How to read this evidence
A report of individual cases can highlight a possible safety signal. It cannot show how often an event occurs or prove that the peptide caused it.
Results in context
The case identifies a serious toxicity signal including muscle breakdown and renal dysfunction. It cannot determine how commonly this occurs or characterize every marketed preparation.
What this does not establish
A single case cannot estimate the frequency of adverse events or establish a safe exposure level.
Publication & source
Why this paper is included
The compound is a named subject of the publication title.